➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Harvard Business School
McKinsey
Merck
Dow

Last Updated: July 7, 2020

DrugPatentWatch Database Preview

CEREZYME Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for CEREZYME

Identify potential brand extensions & biosimilar entrants

SponsorPhase
SanofiN/A
National Taiwan University HospitalN/A
SanofiPhase 3

See all CEREZYME clinical trials

Recent Litigation for CEREZYME

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
MiMedx Group, Inc. v. Tissue Transplant Technology, Ltd.2014-05-16

See all CEREZYME litigation

Company Disclosures: US Patents for CEREZYME

These patents were extracted from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genzyme CEREZYME imiglucerase INJECTABLE;INJECTION 020367 001 1995-04-07   Start Trial Genzyme Corporation (Cambridge, MA) 2010-08-17 RX company
Genzyme CEREZYME imiglucerase INJECTABLE;INJECTION 020367 001 1995-04-07   Start Trial Genzyme Corporation (Cambridge, MA) 2013-08-27 RX company
Genzyme CEREZYME imiglucerase INJECTABLE;INJECTION 020367 002 1995-04-07   Start Trial Genzyme Corporation (Cambridge, MA) 2010-08-17 RX company
Genzyme CEREZYME imiglucerase INJECTABLE;INJECTION 020367 002 1995-04-07   Start Trial Genzyme Corporation (Cambridge, MA) 2013-08-27 RX company
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Patent Text Search: US Patents for CEREZYME

These patents were identified by searching patent claims

Supplementary Protection Certificates for CEREZYME

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C300722 Netherlands   Start Trial PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720
122015000021 Germany   Start Trial PRODUCT NAME: TOBRAMYCIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/10/652/001-003 20110720
92678 Luxembourg   Start Trial PRODUCT NAME: TOBRAMYCINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE QUI EN DERIVE. FIRST REGISTRATION: 20110725
C01280520/01 Switzerland   Start Trial PRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 60565 01.02.2012
14/2015 Austria   Start Trial PRODUCT NAME: TOBRAMYCIN ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/10/652/001-003 20110720
CA 2015 00017 Denmark   Start Trial PRODUCT NAME: TOBRAMYCIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/10/652/001-003 20110720
300722 Netherlands   Start Trial PRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
McKinsey
AstraZeneca
Mallinckrodt
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.